Table 1.

Biomarkers, laboratory analyses methods and definitions of cardiometabolic risk, 2009 China Health and Nutrition Survey fasting blood samples

Biomarker	Risk Indicator	Definition
Glucose	Impaired fasting glucose	Glucose ≥ 100 & < 126 mg/dL
	Diabetes	Glucose ≥ 126 mg/dL or taking diabetes medication
HbA1C	Impaired glucose control	HbA1c ≥ 5.7 & < 6.5%
	Diabetes	HbA1c ≥ 6.5% or taking diabetes medication
Total Cholesterol	High TC	≥ 200 mg/dL
HDL-C	Low HDL	Male: < 40 mg/dL; female < 50 mg/dL; pediatric < 40 mg/dL
LDL-C	High LDL	> 130 mg/dL
Triglycerides	High TG	≥ 150 mg/dL
High Sensitivity CRP	High GRP	≥ 3 mg/dL